Northwest Biotherapeutics (NWBO) Non-cash Items (2016 - 2026)
Northwest Biotherapeutics (NWBO) recorded Non-cash Items of -$2.99 million in Q2 2026, compared with $3.82 million a year earlier.
Powered by 
Analysis
Northwest Biotherapeutics (NWBO) Non-cash Items (2016 - 2026) Analysis & Trends
On a TTM basis, Northwest Biotherapeutics' Non-cash Items came in at -$15.47 million as of Jun 30, 2026; for FY2025, it was $2.44 million, down 85.5% from FY2024.
- Annual Non-cash Items has a five-year compound annual growth rate of -65.5% (FY2020 to FY2025).
- Across earlier years, Non-cash Items came in at $16.76 million in FY2024 (+32.4%), $12.66 million in FY2023 (-71.9%), $45.05 million in FY2022 and -$220.15 million in FY2021.
- Quarterly Non-cash Items has ranged from -$143.87 million in Q4 2021 to $16.96 million in Q3 2022 over the past five years.
- On a year-over-year basis, Non-cash Items rose in four of the last five quarters, with growth averaging 120.0%.
- Peak year-over-year performance for Non-cash Items in the last five years was growth of 355.2% in Q2 2025, against a decline of 87.3% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at -$7.55 million (Q1 2026), -$15.22 million (Q4 2025) and $10.29 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Northwest Biotherapeutics | 250.40 Mn | 240.41 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.99 Mn |
| Mar 31, 2026 | -7.55 Mn |
| Dec 31, 2025 | -15.22 Mn |
| Sep 30, 2025 | 10.29 Mn |
| Jun 30, 2025 | 3.82 Mn |
| Mar 31, 2025 | 3.55 Mn |
| Dec 31, 2024 | 5.95 Mn |
| Sep 30, 2024 | 7.34 Mn |
| Jun 30, 2024 | 839,000.00 |
| Mar 31, 2024 | 2.63 Mn |
| Dec 31, 2023 | 2.04 Mn |
| Sep 30, 2023 | 9.46 Mn |
| Jun 30, 2023 | 1.69 Mn |
| Mar 31, 2023 | -533,000.00 |
| Dec 31, 2022 | 16.04 Mn |
| Sep 30, 2022 | 16.96 Mn |
| Jun 30, 2022 | 11.41 Mn |
| Mar 31, 2022 | 636,000.00 |
| Dec 31, 2021 | -143.87 Mn |
| Sep 30, 2021 | -56.38 Mn |
API Access
Northwest Biotherapeutics Non-cash Items API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-cash-items&ticker=NWBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-cash-items", "ticker": "NWBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-cash-items&ticker=NWBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();